CCCC · C4 Therapeutics, Inc.
$3.58
-0.11 (-2.98%)
At close · Jul 20
Market Cap
$395.83M
Shares
110.57M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-24 | — | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-05-15 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-29 | — | |
| 8-K | 2026-04-10 | — | |
| 8-K | 2026-04-09 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-14 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-16 | — | |
| 8-K | 2025-10-16 | — | |
| 8-K | 2025-10-01 | — | |
| 8-K | 2025-09-22 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-18 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-29 | — | |
| 8-K | 2025-04-14 | — | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2024-12-09 | — | |
| 8-K | 2024-11-20 | — | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K/A | 2024-10-16 | 2024-10-15 | |
| 8-K | 2024-10-15 | — | |
| 8-K | 2024-10-11 | — | |
| 8-K | 2024-09-03 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-08-01 | — | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-06-10 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-29 | — | |
| 8-K | 2024-03-08 | — | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-02-22 | — | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-01-11 | — | |
| 8-K | 2024-01-09 | — | |
| 8-K | 2023-12-12 | — |
Showing 1–50 of 107 filings